Profits fall for pharmaceutical company CSL to $US1.62 billion

  • 📰 SkyNewsAust
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 78%

United States News News

United States United States Latest News,United States United States Headlines

Blood products and pharmaceuticals company CSL saw their profit for the first half year fall eight per cent to $US1.62 billion as the result of one-off costs associated with its $16 billion takeover of Swiss company Vifor Pharma.

It’s also the final result from Chief Executive Paul Perreault – who has headed the

company for almost 10 years, where CSL shares have increased more than three-and-a-half times.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 7. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

How the hell can this mob lose money 💵 with what they charge for a blood transfusion 😱

Sir in my family there are 7 members mother, father old age with their medicine it is impossible to run the family. I owe a lot of money and now I am bankrupt. Please give me a work visa so that I and my family can live.

United States United States Latest News, United States United States Headlines